[go: up one dir, main page]

CY1116170T1 - METHOD OF PREPARING RECOVERY ANTI-TUMORABLE ANTIBODIES - Google Patents

METHOD OF PREPARING RECOVERY ANTI-TUMORABLE ANTIBODIES

Info

Publication number
CY1116170T1
CY1116170T1 CY20151100334T CY151100334T CY1116170T1 CY 1116170 T1 CY1116170 T1 CY 1116170T1 CY 20151100334 T CY20151100334 T CY 20151100334T CY 151100334 T CY151100334 T CY 151100334T CY 1116170 T1 CY1116170 T1 CY 1116170T1
Authority
CY
Cyprus
Prior art keywords
tumorable
antibodies
recovery anti
preparing recovery
preparing
Prior art date
Application number
CY20151100334T
Other languages
Greek (el)
Inventor
Egbert Dr Oosterwijk
Sven Prof Warnaar
Stefan Dr Ullrich
Original Assignee
Wilex Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from EP06014768.3A external-priority patent/EP1733736B1/en
Application filed by Wilex Ag filed Critical Wilex Ag
Publication of CY1116170T1 publication Critical patent/CY1116170T1/en

Links

Landscapes

  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

Abstract

Η εφεύρεση αφορά στην χρήση ενός G250 αντισώματος για την βιομηχανική κατασκευή μιας φαρμακοτεχνικής μορφής για την θεραπεία ασθενών με καρκίνωμα νεφρικού κυττάρου μετά από χειρουργείο και την χρήση ενός G250 αντισώματος για την βιομηχανική κατασκευή ενός παράγοντα για να προκαλείται μια καθυστερημένη ανοσοαπόκριση σε έναν ασθενή με καρκίνωμα νεφρικού κυττάρου.The invention relates to the use of a G250 antibody for the manufacture of a formulation for the treatment of patients with renal cell carcinoma after surgery and the use of a G250 antibody for the manufacture of an agent to induce a delayed immune response in a cancer patient. cell.

CY20151100334T 2001-02-07 2015-04-07 METHOD OF PREPARING RECOVERY ANTI-TUMORABLE ANTIBODIES CY1116170T1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US26685301A 2001-02-07 2001-02-07
US32700801A 2001-10-05 2001-10-05
EP06014768.3A EP1733736B1 (en) 2001-02-07 2002-02-07 Method of producing recombinant antibodies against tumours

Publications (1)

Publication Number Publication Date
CY1116170T1 true CY1116170T1 (en) 2017-02-08

Family

ID=58457924

Family Applications (1)

Application Number Title Priority Date Filing Date
CY20151100334T CY1116170T1 (en) 2001-02-07 2015-04-07 METHOD OF PREPARING RECOVERY ANTI-TUMORABLE ANTIBODIES

Country Status (1)

Country Link
CY (1) CY1116170T1 (en)

Similar Documents

Publication Publication Date Title
CY1123667T1 (en) PREPARATION OF IMMUNE SPHERINE AND METHOD OF PREPARATION THEREOF
CY2019022I1 (en) HUMAN CDR-GRAVED ANTIBODIES AND ANTIBODY FRAGMENTS THEREOF
CY1112507T1 (en) ANTI-PARTICULAR PARTS SPECIALIZED FOR HUMAN IL-1B
CY1117963T1 (en) IL-17A AND IL-17F ANTIBODIES
HUP0301877A2 (en) Aromatase inhibitors and monoclonal anti-her2 antibodies as antitumors agents
PT1644484E (en) SELF-TOLERANCE INDUCTION SELF-TOLERANCE CELLS OF MONOCYTIC ORIGIN AND THEIR USE IN PHARMACEUTICAL PREPARATIONS
IL163902A0 (en) Antibodies against cancer antigen tmeff2 and uses thereof
CY1113984T1 (en) DM1 conjugate conjugate products with TRASTUZUMAB antibody, CONNECTED THROUGH NON-EXTRACTIVE CONNECTOR AND USE IN TREATMENT TREATMENT
ATE471946T1 (en) HUMANIZED ANTIBODY (H14.18) OF THE MOUSE ANTIBODY 14.18 THAT BINDS GD2 AND ITS FUSION WITH IL-2
UY26807A1 (en) DOUBLE SPECIFICITY ANTIBODIES AND METHODS FOR THE ELABORATION AND USE OF THE SAME
NO20083066L (en) Antibody molecules with specificity for human IL-6
CY1104988T1 (en) METHOD OF TREATMENT OF MIDDLE EAR INFECTIONS
DK2109623T3 (en) Cancer treatment with anti-IL-1 antibodies
CY1110162T1 (en) PHARMACEUTICAL FORM AND METHODS FOR THE TREATMENT OF THROMBOCYTALARIA
DK1411064T3 (en) Ganglioside-associated recombinant antibodies and their use in the diagnosis and treatment of tumors
MXPA04006517A (en) Conjugates comprising an antibody specific for the ed-b domain of fibronectin and their use for the detection and treatment of tumours.
CY1109361T1 (en) Substituted 4-Aminocyclohexanols
CY1113116T1 (en) Substituted 4-Aminocyclohexanols
ATE517340T1 (en) SETS OF DIGITAL ANTIBODIES DIRECTED AGAINST SHORT EPITOPES AND METHODS USING THEM
DK1476468T3 (en) Fab fragments of human monoclonal antibody directed against HCV E2 glycoprotein and with in vitro neutralizing activity
EP1605847A4 (en) PHOTODYNAMIC THERAPY PROVIDED AGAINST ANTIBODIES
NO20040249L (en) Blood group antigen fusion polypeptides and methods for their use
EE05474B1 (en) Use of Antibodies in the Preparation of a Pharmaceutical Composition for Antiviral Vaccination
ITRM20040586A1 (en) ANTIGENIC EPITOPES OF INTERLEUCHINA-21, RELATIVE ANTIBODIES AND THEIR USE IN MEDICAL FIELD.
EA200601386A1 (en) IMMUNE GLOBULINS AGAINST EpCAM ANTIGEN